Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models

The lack of effective treatment modalities is a major problem in pancreatic cancer (PCa), a devastating malignancy that is nearly universally driven by the “undruggable” KRAS and TP53 cancer genes. Poor tumor tissue penetration is the major source of resistance in pancreatic cancer where chemotherap...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Bobrov, Egor, Skobeleva, Natalia, Restifo, Diana, Beglyarova, Natalya, Cai, Kathy Q., Handorf, Elizabeth, Campbell, Kerry, Proia, David A., Khazak, Vladimir, Golemis, Erica A., Astsaturov, Igor
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354841/
https://ncbi.nlm.nih.gov/pubmed/27779106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12642
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares